Prevention Strategies for Healthcare-Associated Pneumonia

Lee E. Morrow

doi:10.1055/s-0028-1119812

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2009; 30(1): 086-091
DOI: 10.1055/s-0028-1119812

Prevention Strategies for Healthcare-Associated Pneumonia

Lee E. Morrow¹

¹Division of Pulmonary, Critical Care, and Sleep Medicine, Creighton University Medical Center, Omaha, Nebraska

Abstract

ABSTRACT

Healthcare-associated pneumonia (HCAP) represents one of the largest subsets of patients with pneumonia. Based on epidemiological projections for the aging U.S. population, the number of hospitalizations for HCAP is expected to increase exponentially for the next several decades. The unique risk factors for colonization with resistant pathogens in these patients provide multiple opportunities for HCAP prevention. However, our current understanding of the most effective prevention measures is woefully inadequate and constitutes an extrapolation from studies done in community-acquired and hospital-acquired pneumonia patients. This review explores common prevention strategies that may be applicable to HCAP, highlights areas of controversy that require further study, and describes several areas of ongoing novel investigation.

KEYWORDS

Pneumonia - cross-infection - prevention and control - nursing homes

Full Text

References

REFERENCES

1 Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society & Infectious Diseases Society of America . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171 388-416
2 Kollef M H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000; 31 S131-S138
3 Luna C M, Vujacich P, Niederman M S et al.. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997; 111 676-685
4 Kollef M H, Sherman G, Ward S, Fraser V J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999; 115 462-474
5 Iregui M, Ward S, Sherman G, Fraser V J, Kollef M H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002; 122 262-268
6 Cosgrove S E, Kaye K S, Eliopoulous G M, Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med. 2002; 162 185-190
7 Guay D RP. Guidelines for the management of adults with healthcare-associated pneumonia: implications for nursing facility residents. Consult Pharm. 2006; 21 719-725
8 Fujitani S, Yu V L. A new category—healthcare-associated pneumonia: a good idea but problems with its execution. Eur J Clin Microbiol Infect Dis. 2006; 25 627-631
9 Micek S T, Kollef K E, Reichley R M, Roubinian N, Kollef M H. Healthcare-associated pneumonia and community-acquired pneumonia: a single center experience. Antimicrob Agents Chemother. 2007; 51 3568-3573
10 Kollef M H, Shorr A, Tabak Y P, Gupta V, Liu L Z, Johannes R S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005; 128 3854-3862
11 Centers for Disease Control . Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. Respir Care. 2004; 49 926-939
12 Brooks K, Whitten S, Quigley D. Reducing the incidence of ventilator-associated pneumonia. J Healthc Qual. 1998; 20 14-19
13 Zack J E, Garrison T, Trovillion E et al.. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med. 2002; 30 2407-2412
14 Garner J S. Guideline for isolation precautions in hospitals: the Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996; 17 53-80
15 Boyce J M, Pittet D. Healthcare Infection Control Practices Advisory Committee: HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force . Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002; 51(RR-16) 1-45 , quiz CE1-4
16 Pittet D, Hugonnet S, Harbarth S et al.. Effectiveness of a hospital-wide program to improve compliance with hand hygiene. Lancet. 2000; 356 1307-1312
17 Sehulster L, Chinn R Y. CDC; HICPAC . Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICAC). MMWR Recomm Rep. 2003; 52(RR-10) 1-42
18 Food and Drug Administration .Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals. Rockville, MD; US DHHS, FDA 2000
19 van Grafhorst J P, Foudraine N A, Nooteboom F, Crombach W H, Oldenhof N J, van Doorne H. Unexpected high risk of contamination with Staphylococci species attributable to standard preparation of syringes for continuous intravenous drug administration in a simulation model in intensive care units. Crit Care Med. 2002; 30 833-836
20 Trick W E, Weinstein R A, DeMarais P L et al.. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc. 2004; 52 2003-2009
21 Osono E, Takahashi M, Kuihara S et al.. Effects of “isolating hemodialysis” on prevention of methicillin-resistant Staphylococcus aureus cross-infection in a hemodialysis unit. Clin Nephrol. 2000; 54 128-133
22 Kotilainen P, Routamaa M, Peltonen R et al.. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med. 2001; 161 859-863
23 Silverblatt F J, Tibert C, Mikolich D et al.. Preventing the spread of vancomycin-resistant enterococci in a long-term facility. J Am Geriatr Soc. 2000; 48 1211-1215
24 Dear K, Holden J, Andres R, Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2003; 4 CD000422
25 Fisman D N, Abrutyn E, Spaude K A, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006; 42 1093-1101
26 Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 2004; 23 363-368
27 Vila-Corcoles A, Ochoa-Gondar O, Llor C, Hospital I, Rodriguez T, Gomez A. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J. 2005; 26 1086-1091
28 Janssens J P, Krause K H. Pneumonia in the very old. Lancet Infect Dis. 2004; 4 112-124
29 Whitney C G, Farley M M, Hadler J et al.. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003; 348 1737-1746
30 Ortqvist A, Hedlund J, Burman L A et al.. Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people: Swedish Pneumococcal Vaccination Study Group. Lancet. 1998; 351 399-403
31 Potter J, Stott D J, Roberts M A et al.. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997; 175 1-6
32 Carman W F, Elder A G, Wallace L A et al.. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet. 2000; 355 93-97
33 Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997; 46(No. RR-8) 1-24
34 Hutt E, Kramer A M. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract. 2002; 51 709-716
35 Loeb M, McGeer A, McArthur M, Walter S, Simor A E. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 1999; 159 2058-2064
36 Fine M J, Smith M A, Carson C A et al.. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med. 1994; 154 2666-2677
37 Ortqvist A, Hedlund J, Burman L et al.. Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet. 1998; 351 399-403
38 Koivula I, Sten M, Leinonen M, Makela P H. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med. 1997; 103 281-290
39 Gross P A, Hermogenes A W, Sacks H S, Lau J, Levandowski R A. The efficacy of influenza vaccine in elderly persons. Ann Intern Med. 1995; 123 518-527
40 Muszkat M, Greenbaum E, Ben Yehuda A et al.. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivate influenza vaccine. Vaccine. 2003; 21 1180-1186
41 Olive K E, Berk S L. Infections in the nursing home. Clin Geriatr Med. 1992; 8 821-834
42 Naqvi S B, Collins A J. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis. 2006; 13 199-204
43 Marrie T J. Pneumonia in the long-term-care facility. Infect Control Hosp Epidemiol. 2002; 23 159-164
44 Drakulovic M B, Torres A, Bauer T T, Nicolas J M, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet. 1999; 354 1851-1858
45 Torres A, Serra-Batlles J, Ros E et al.. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 1992; 116 540-543
46 Celis R, Torres A, Gatell J M, Almela M, Rodriguez-Roisin R, Augusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest. 1988; 93 318-324
47 Gillick M R. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med. 2000; 342 206-210
48 Loeb M B, Backer M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. 2003; 51 1018-1022
49 Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis. 2005; 40 1-6
50 Leder S B. Videofluoroscopic evaluation of aspiration with visual examination of the gag reflex and velar movement. Dysphagia. 1997; 12 21-23
51 Leder S B. Gag reflex and dysphagia. Head Neck. 1996; 18 138-141
52 Marik P E, Kaplan M A. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003; 124 328-336
53 Yoneyama T, Yoshida M, Ohrui T et al.. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc. 2002; 50 430-433
54 Chlebicki M P, Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2007; 35 595-602
55 Bergmans D C, Bonten M J, Gaillard C A et al.. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001; 164 382-388
56 Laheij R J, Sturkenboom M C, Hassing R J, Dieleman J, Stricker B H, Jansen J B. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004; 292 1955-1960
57 Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, de Champs C. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care. 2008; 12 R69
58 Ardigo D, Valtuena S, Zavaroni I, Baroni M C, Delsignore R. Pulmonary complications in diabetes mellitus: the role of glycemic control. Curr Drug Targets Inflamm Allergy. 2004; 3 455-458
59 Nuorti J P, Butler J C, Farley M M et al.. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000; 342 681-689
60 van de Garde E M, Souverein P C, Hak E, Deneer V H, van den Bosch J M, Leufkens H G. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens. 2007; 25 235-239
61 Teramoto S, Yamamoto H, Yamaguchi Y et al.. ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke. Eur Respir J. 2007; 29 218-219

Lee E MorrowM.D. M.Sc.

Division of Pulmonary, Critical Care, and Sleep Medicine, Creighton University Medical Center

601 North 30th St., Ste. #3820, Omaha, NE 68131

Email: lmorrow@creighton.edu